Clinical Trial Update: Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating abciximab to prevent stroke recurrence before carotid endarterectomy in symptomatic carotid stenosis was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Stenosis
• Stroke

Drugs mentioned

• ReoPro (abciximab)

Snippet

Sponsor: University of Zurich | Conditions: Stroke, Stenosis | Phase 3 | Status: TERMINATED